23rd Annual Meeting of the German Retina Society
German Retina Society
24.09. - 25.09.2010, Freiburg
II. Age Related Macular Degeneration – Therapy
Meeting Abstract
(10rg09)
[Full Text]
Serous Retinal Pigment Epithelium Detachment within Exudative Age-related Macular Degeneration – Anti-VEGF Therapy
Lommatzsch A, Heimes B, Spital G, Dietzel M, Gutfleisch M, Pauleikhoff D[Full Text]
Meeting Abstract
(10rg10)
[Full Text]
Treatment of serous pigment-epithelium-layer-elevation (PED) by intravitreal injections of Ranibizumab and Bevacizumab
Altmann M, Radeck V, Helbig H, Gamulescu A[Full Text]
Meeting Abstract
(10rg11)
[Full Text]
Pigment epithelium tears following intravitreal anti-VEGF-therapy for vascularised pigment epithelium detachment (PED) in AMD: development of morphology and visual acuity
Gutfleisch M, Heimes B, Schuhmacher M, Spital G, Lommatzsch A, Pauleikhoff D[Full Text]
Meeting Abstract
(10rg12)
[Full Text]
Treatment of wet-age related macular degeneration (AMD) with rt-PA and anti-VEGF
Schmidt JC, Thimm CBG[Full Text]
Kongressabstract
(10rg13)
[Full Text]
Intravitreale Injektion von Bevacizumab, recombinant tissue plasminogen activator (rTPA) und Gas bei der Behandlung von submakulärer Blutung bei der AMD
Guthoff R, Meigen T, Guthoff T, Göbel W[Full Text]
Meeting Abstract
(10rg14)
[Full Text]
Individual Recurrence Intervals After Ranibizumab Therapy For neovascular Age-related Macular Degeneration
Hörster R, Ristau T, Kirchhof B, Liakopoulos S[Full Text]
Meeting Abstract
(10rg15)
[Full Text]
Statistical analyses, modelling of response characteristics, saturation of therapy and optimum of AMD treatment with less than 12 injections of Rainibizumab/year
Gerding H, Timmermann M, Hefner L[Full Text]
Meeting Abstract
(10rg16)
[Full Text]
Delay between medical indication to anti-VEGF treatment in age-related macular degeneration can result in loss of visual acuity
Müther PS, Hermann MM, Koch K, Kirchhof B, Fauser S[Full Text]
